The Rise of Domain Experts in Deep Learning

Jeremy Howard and Derrick Harris

Jeremy Howard of discusses the impacts of deep learning and AI now being accessible to people without PhDs in those spaces.

When to Expand Your Marketplace Business, According to 14 Operators

Justine Moore and John Koelliker

Takeaways from 30 successful marketplaces—including Uber, Airbnb, and Tinder—on when, where, and how to grow.

Info Diet: a16z Crypto’s Elena Burger

Elena Burger

The a16z crypto deal partner dives down an AI rabbit hole, ponders web3 applications for streaming, and tracks the Ethereum Merge.

The Glittering Treasure in Your Genome’s Junk

Rick Young, Jorge Conde, and Hanne Winarsky

A Q&A with MIT Professor Rick Young about the roles of the 98% of the human genome that does not code for proteins -- known as non-coding DNA or junk DNA.

Sales Enablement: The Underrated Cog of Enterprise Commercial Engines

Vassilis Tziokas

Sales enablement — the use of people, processes, and tech to improve sales productivity — is key for a well-oiled, agile, and high-performing sales machine.

Quantifying Disease Risk Using Genomics: the New Paradigm

Peter Donnelly, Vineeta Agarwala, and Lauren Richardson

How polygenic risk scores use genetics to predict your chance for common diseases and how this helps us shift from 'sick care' to preventative medicine.

Ransomware, Cyber-Savviness, and the Public-Private Security Connection

Nitin Natarajan and Joel de la Garza

CISA deputy director Nitin Natarajan and a16z general partner Joel de la Garza discuss ransomware, cyber-savviness, and industry-government partnerships.

Mid-year Recap: Web3 and Science Collide

Future Editorial

The first half of 2022 saw momentum gains for a movement at the intersection of web3 and science: decentralized science (DeSci).

Crypto/Web3 So Far in 2022

Future Editorial

Seven pieces that cover some of the big ideas, movements, and research areas in crypto and web3 over the last several months.

Recognizing the Next CRISPR-Level Tech for Biology

Jennifer Doudna and Vijay Pande

A Q&A with Jennifer Doudna. She shares thoughts on recognizing game-changing biology tools, what she's struggling with, and what may never be engineerable.